Medical Guidance Systems — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Medical Guidance Systems is a developer of software-driven guidance and navigation systems for surgical and medical procedures. Founded in 2012 and operating privately, the company appears to be in a pre-revenue or early-revenue stage, leveraging its San Diego location within a major biotech hub. The company's positioning in antibodies, biologics, and drug delivery sectors indicates a targeted approach to improving precision and outcomes for complex therapeutic interventions. Its lack of detailed public information suggests it is likely in a stealth or early commercial development phase.

OncologyOrthopedicsNeurology

Technology Platform

Software and integrated hardware systems for real-time image-guided surgical navigation and procedural targeting, potentially specialized for the precise delivery of biologics and therapeutic agents.

Opportunities

The growing market for minimally invasive, precision-based delivery of high-value biologics and cell therapies presents a major opportunity.

The company could establish a new standard of care for targeted drug delivery, creating significant value for pharmaceutical partners.

Its platform approach allows for expansion into multiple therapeutic areas beyond an initial focus.

Risk Factors

The company faces intense competition from large, established medical device companies with vast sales networks and integrated product suites.

Regulatory hurdles for new software-as-a-medical-device (SaMD) platforms can be complex and unpredictable.

As a pre-revenue private company, it carries high financial risk and dependence on investor funding.

Competitive Landscape

The competitive landscape includes large-cap medtech players like Medtronic (StealthStation), Stryker (Mako, NAV3i), and Brainlab, which dominate broad surgical navigation. Medical Guidance Systems appears to differentiate by focusing specifically on the guidance for biologic and drug delivery, a more specialized niche. It may also compete with or complement companies developing specialized drug delivery devices or image-guidance software for interventional radiology and oncology.

More companies in Biologics / Biosimilars →More companies in United States →